8Chou MM,Mackenzie IZ. A prospective,double-blind,randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2α 125 micrograms and intravenous oxytocin, 20units for the control of blood loss at elective cesarean section. Am J Obstet Gynecol. 1994,17(5) : 1356~1360.
2Institute for Safe Medication Practices.ISMP' s List of High-Alert Medications[EB/OL].2012-01-30.[2014-05-17].http://www.ismp.org/Tools/institutionalhighAlert.asp.
4Bates DW,Boyle DL,Vander Vliet MB et al.relationship between medication errors and adverse drug events[J].J Gen Intern Med,1995,10:199-205.
5Clark SL,Belfort MA,Dildy GA,et al.Reducing obstetric litigationg through alterations in practice patterns-experience with 189closed claims[J].Obstet Gynecol,2008,112(6):1279-1283.
6Simpson KR,Knox GE.Oxytocin as a high-alert medication:implications for perinatal patient safety[J].MCN Am J Matern Child Nurs,2009,34(1):8-15.